Similar articles

• US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.

  Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM, Chen IY, Chen X, Gambhir SS. Willmann JK, et al. Radiology. 2008 Feb;246(2):508-18. doi: 10.1148/radiol.2462070536. Epub 2008 Jan 7. Radiology. 2008. PMID: 18180339 Free PMC article.
• BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.

  Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M. Pochon S, et al. Invest Radiol. 2010 Feb;45(2):89-95. doi: 10.1097/RLI.0b013e3181c5927c. Invest Radiol. 2010. PMID: 20027118
• Can the effect of antiangiogenic treatments be monitored and quantified noninvasively by using contrast-enhanced US?

  Forsberg F. Forsberg F. Radiology. 2010 Feb;254(2):317-8. doi: 10.1148/radiol.091853. Radiology. 2010. PMID: 20093504
• A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.

  Lim EH, Danthi N, Bednarski M, Li KC. Lim EH, et al. Nanomedicine. 2005 Jun;1(2):110-4. doi: 10.1016/j.nano.2005.03.008. Nanomedicine. 2005. PMID: 17292065 Review. No abstract available.
• Scoping Review of Targeted Ultrasound Contrast Agents in the Detection of Angiogenesis.

  Lau C, Rivas M, Dinalo J, King K, Duddalwar V. Lau C, et al. J Ultrasound Med. 2020 Jan;39(1):19-28. doi: 10.1002/jum.15072. Epub 2019 Jun 24. J Ultrasound Med. 2020. PMID: 31237009